GlassScriptPhysician profile
Meshelle L Howd
NPI 1316985104
$1,634.22
in general payments reported to CMS, 2019-2025
16 companies · $646 in 2025
The $646 reported for 2025 was more than what 76% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $59.88 · 2022: $249 · 2023: $178 · 2024: $501 · 2025: $646.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,112 · Education: $213.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,112.00 |
| Education | $213.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $502.98 | 2023-2025 | Tremfya |
| Regeneron Healthcare Solutions, INC. | $279.00 | 2022-2025 | Dupixent, Libtayo |
| E.R. Squibb & Sons, L.L.C. | $255.53 | 2023-2025 | Sotyktu |
| Abbvie INC. | $113.96 | 2023-2025 | |
| Sun Pharmaceutical Industries INC. | $81.21 | 2021-2022 | |
| Genzyme Corporation | $62.74 | 2025 | |
| Organon LLC | $61.15 | 2025 | Vtama |
| Novartis Pharmaceuticals Corporation | $56.53 | 2021-2025 | |
| Galderma Laboratories, L.P. | $49.61 | 2022-2024 | |
| Amgen INC. | $41.91 | 2025 | Otezla |
| Allergan, INC. | $39.91 | 2022 | |
| Ucb, INC. | $23.80 | 2025 | Bimzelx |
| Incyte Corporation | $18.13 | 2023 | Opzelura |
| Almirall LLC | $17.56 | 2022 | |
| Pfizer INC. | $17.03 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $13.17 | 2025 | Tremfya |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Meshelle Howd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.